(Q36684524)

15 August 2017

1 reference

title

The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma (English)

1 reference

15 August 2017

1 reference

1

Eli O Meltzer

1 reference

15 August 2017

Sally Wenzel

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

43

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

765-772

1 reference

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Evolution of dry powder inhaler design, formulation, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Once-daily evening administration of mometasone furoate in asthma treatment initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

21 January 2018

Chronobiology of asthma

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy,

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

Drug delivery performance of the mometasone furoate dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900601031722

10.1080/02770900601031722

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference